Imihype C 1000 Injection containing Imipenem and Cilastatin is used for the management of severe and life-threatening bacterial infections. It provides broad-spectrum antibacterial coverage and is used in critical care settings for resistant infections.
Imipenem is a carbapenem antibiotic that inhibits bacterial cell wall synthesis and provides strong broad-spectrum activity, while Cilastatin helps inhibit renal metabolism of Imipenem, increasing its stability and effectiveness in the body.
The injection is widely prescribed in intensive care units and hospital settings for serious infections including respiratory, abdominal, urinary tract, and systemic infections, leading to consistent prescription demand.
With the increasing burden of multidrug-resistant infections and growing demand for advanced critical care antibiotics, this product offers strong business potential for hospitals, retailers, and distributors. Its high-end formulation, established clinical efficacy, and strong market demand make it a reliable product for growth in the critical care segment.